The Optic Ultrasound Gastroscope segmentation by application distinguishes three primary sub‑categories: diagnostic, therapeutic, and research. Diagnostic gastroscopy leverages high‑resolution imaging to identify mucosal lesions, ulcerations, and early neoplasms, accounting for roughly 45 % of total market revenue due to its pervasive use in routine gastro‑enterology clinics. Therapeutic applications, representing about 35 % of the market, involve real‑time ultrasound guidance for interventions such as submucosal dissections, hemostasis, and targeted drug delivery, which command higher unit prices and longer procedure times. Research‑focused deployments, while smaller at an estimated 20 % share, drive innovation through pre‑clinical studies and clinical trials, influencing future product development and regulatory pathways. Collectively, these application segments shape the overall market size by dictating demand intensity, pricing structures, and investment in technology upgrades, thereby providing a clear taxonomy for revenue attribution across the Optic Ultrasound Gastroscope landscape.